Order Article Reprints

Källsten M, Hartmann R, Kovac L, Lehmann F, Lind SB, Bergquist J. Investigating the Impact of Sample Preparation on Mass Spectrometry-Based Drug-To-Antibody Ratio Determination for Cysteine- and Lysine-Linked Antibody–Drug Conjugates. Antibodies. 2020; 9(3):46. https://doi.org/10.3390/antib9030046

Källsten, Malin, Rafael Hartmann, Lucia Kovac, Fredrik Lehmann, Sara Bergström Lind, and Jonas Bergquist. 2020. "Investigating the Impact of Sample Preparation on Mass Spectrometry-Based Drug-To-Antibody Ratio Determination for Cysteine- and Lysine-Linked Antibody–Drug Conjugates" Antibodies 9, no. 3: 46. https://doi.org/10.3390/antib9030046

Källsten, M., Hartmann, R., Kovac, L., Lehmann, F., Lind, S. B., & Bergquist, J. (2020). Investigating the Impact of Sample Preparation on Mass Spectrometry-Based Drug-To-Antibody Ratio Determination for Cysteine- and Lysine-Linked Antibody–Drug Conjugates. Antibodies, 9(3), 46. https://doi.org/10.3390/antib9030046